Literature DB >> 14631393

Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease.

J Dart1.   

Abstract

Corneal toxicity is caused by chemical trauma and by iatrogenic and factitious disease, which are often overlooked, and which are reviewed here. The clinical signs of iatrogenic disease are usually nonspecific and identical to those resulting from other causes of surface disease. Factitious disease is either the result of mechanical trauma or the abuse of toxic eye drops. One epidemiological study, in a tertiary setting, identified 13% of keratoconjunctivitis cases as iatrogenic. Healing was prolonged taking 7-93 (median 28.5) days. Pathogenic mechanisms vary widely with different drugs and include subclinical scarring, pseudopemphigoid, drug-induced ocular cicatricial pemphigoid, and toxic follicular reactions. There is little readily available data either on the probability of the development of adverse reactions or for the comparison of different drugs. The assessment of the toxicity of topical drugs is currently by the Draize test in rabbits. New in vitro tests on human corneal epithelial cell cultures include ATP assays for cell viability, scanning EM of epithelial microvilli, and vital staining to assess cell membrane permeability and intracellular esterase. Despite their simplicity, these test systems can correlate well with clinical toxicity and provide a toxicity index for drug comparisons. Treatment requires drug withdrawal or substitution by non-preserved and less toxic preparations. Factitious injury is rare, difficult to diagnose, and should only be considered when all other diagnoses have been excluded. Prevention requires a high level of awareness of the potential for iatrogenic disease, particularly in the high-risk setting of chronic ocular surface disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631393     DOI: 10.1038/sj.eye.6700576

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  14 in total

1.  Cytotoxic effect and possible mechanisms of Tetracaine on human corneal epithelial cells in vitro.

Authors:  Xin Pang; Ting-Jun Fan
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

Review 2.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

3.  The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.

Authors:  M Victoria De Rojas; John K G Dart; Valerie P J Saw
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

4.  The role of difluprednate ophthalmic emulsion in clinical practice.

Authors:  Karim N Jamal; David G Callanan
Journal:  Clin Ophthalmol       Date:  2009-06-29

5.  Corneal deposit of ciprofloxacin after laser assisted subepithelial keratomileusis procedure: a case report.

Authors:  Giacomo De Benedetti; Andrea Brancaccio
Journal:  J Ophthalmol       Date:  2010-06-16       Impact factor: 1.909

6.  Over-Treated Corneal Abscess May Be Toxic Keratopathy.

Authors:  P Rubino; J G Orsoni; A Rampini; P Mora
Journal:  Case Rep Ophthalmol       Date:  2010-06-11

7.  Do topical ocular antihypertensives affect Dacryocystorhinostomy outcomes: The Coventry experience.

Authors:  Priyanka Mandal; Harpreet Ahluwalia
Journal:  Eye (Lond)       Date:  2021-02-26       Impact factor: 3.775

8.  Factitious pseudo-membranous conjunctivitis in an adolescent boy.

Authors:  Jelka G Orsoni; Pierangela Rubino; Isabella Pellistri; Chiara Menozzi; Laura Zavota; Antonino Massaro; Paolo Mora
Journal:  Case Rep Ophthalmol       Date:  2011-02-18

9.  Strong topical steroid, NSAID, and carbonic anhydrase inhibitor cocktail for treatment of cystoid macular edema.

Authors:  Masumi G Asahi; Gabriela L Bobarnac Dogaru; Spencer M Onishi; Ron P Gallemore
Journal:  Int Med Case Rep J       Date:  2015-12-01

10.  Managing ocular surface disease: a common-sense approach.

Authors:  Hon Shing Ong; John Kg Dart
Journal:  Community Eye Health       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.